C the Signs uses artificial intelligence to help healthcare professionals detect cancer earlier by analyzing patient symptoms, clinical data, and risk factors in real time to suggest diagnostic and referral pathways. It integrates into primary care and broader health system workflows, translating complex cancer guidelines into practical decisions across all cancer types, including rare ones. The platform supports faster referrals, reduces diagnostic delays, and enables more personalized cancer care while focusing on population health to identify disparities and align with national targets. Its goal is to improve patient outcomes by enabling earlier diagnosis and scalable, data-driven cancer care across health systems.
Company Size
11-50
Company Stage
Early VC
Total Funding
$14.7M
Headquarters
London, United Kingdom
Founded
2017
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?